Edition:
United States

Foundation Medicine Inc (FMI.OQ)

FMI.OQ on NASDAQ Stock Exchange Global Select Market

50.20USD
17 Nov 2017
Change (% chg)

$0.95 (+1.93%)
Prev Close
$49.25
Open
$49.35
Day's High
$50.20
Day's Low
$48.10
Volume
33,715
Avg. Vol
51,332
52-wk High
$55.95
52-wk Low
$17.15

Select another date:

Wed, Nov 1 2017

BRIEF-Foundation Medicine Q3 loss per share $0.90

* Foundation Medicine announces 2017 third quarter results and recent highlights

BRIEF-Foundation Medicine receives approval from state of New York for foundation act liquid biopsy assay

* Foundation Medicine Inc - receives approval from state of New York for foundation act liquid biopsy assay Source text for Eikon: Further company coverage:

BRIEF-Foundation Medicine and Roche enters into a fifth amendment to Collaboration Agreement

* Foundation Medicine Inc - On September 8, company and Roche entered into a fifth amendment to Collaboration Agreement - SEC filing

BRIEF-Foundation Medicine Q2 revenue $35 mln

* Foundation Medicine announces 2017 second quarter results and recent highlights

BRIEF-Foundation Medicine entered into amendment letter agreement with Roche Finance

* Foundation Medicine Inc - co entered into amendment letter agreement with Roche Finance Ltd amending credit facility agreement, dated August 2, 2016

BRIEF-Kura Oncology ‍enters into collaboration agreement with Foundation Medicine ​

* Kura Oncology Inc - ‍entered into a collaboration agreement with Foundation Medicine, Inc.​

Select another date: